Antigen presentation in EAE: Role of microglia, macrophages and dendritic cells

Frontiers in Bioscience

Volumn 16, Issue 3, 2011, Pages 1157-1171

  Almolda, Beatriz ^a   Gonzalez, Berta ^a   Castellano, Bernardo ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

CNS; Dendritic cells; EAE; MHC; Microglia; Neuroimmunology; Review; T cell; Tolerance

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ANTIGEN PRESENTATION; DENDRITIC CELL; IMMUNOLOGY; MACROPHAGE; MICROGLIA; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MACROPHAGES; MICROGLIA;

EID: 79955042876     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3781     Document Type: Review

References (176)

1. Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19, 312-8 (1996) (Pubitemid 26349059)
2. Aloisi F: Immune function of microglia. Glia 36, 165-79 (2001) (Pubitemid 33055905)
3. Carson MJ: Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 40, 218-31 (2002) (Pubitemid 35337379)
4. Ling EA: Transformation of monocytes into amoeboid microglia in the corpus callosum of postnatal rats, as shown by labelling monocytes by carbon particles. J Anat 128, 847-58 (1979) (Pubitemid 9208015)
5. Ling EA, D Penney , CP Leblond: Use of carbon labeling to demonstrate the role of blood monocytes as precursors of the 'ameboid cells' present in the corpus callosum of postnatal rats. J Comp Neurol 193, 631-57 (1980) (Pubitemid 11233741)
6. Ling EA: The origin and nature of microglia. In: Advances in Cellular Neurobiology. Eds: S Federof, L Hertz. Academic Press, New York (1981)
7. Ling EA, W C Wong: The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7, 9-18 (1993)
8. Dalmau I, B Finsen, N Tonder, J Zimmer, B Gonzalez, B Castellano: Development of microglia in the prenatal rat hippocampus. J Comp Neurol 377, 70-84 (1997) (Pubitemid 27023827)
9. Kaur C, AJ Hao, CH Wu, EA Ling: Origin of microglia. Microsc Res Tech 54, 2-9 (2001) (Pubitemid 32537328)
10. Dalmau I, JM Vela, B Gonzalez, B Finsen, B Castellano: Dynamics of microglia in the developing rat brain. J Comp Neurol 458, 144-57 (2003) (Pubitemid 36330471)
11. Williams K, X Alvarez, AA Lackner: Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36, 156-64 (2001) (Pubitemid 33055904)
12. Lawson LJ, VH Perry, S Gordon: Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48, 405-15 (1992)
13. Santambrogio L, SL Belyanskaya, FR Fischer, B Cipriani, CF Brosnan, P Ricciardi-Castagnoli, LJ Stern, JL Strominger, R Riese: Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A 98, 6295-300 (2001) (Pubitemid 32488233)
14. Bechmann I, E Kwidzinski, AD Kovac, E Simburger, T Horvath, U Gimsa, U Dirnagl, J Priller, R Nitsch: Turnover of rat brain perivascular cells. Exp Neurol 168, 242-9 (2001) (Pubitemid 32289760)
15. Almolda B, B Gonzalez, B Castellano: Activated microglial cells acquire an immature dendritic cell phenotype and may terminate the immune response in an acute model of EAE. J Neuroimmunol 223, 39-54 (2010)
16. Dijkstra CD, EA Dopp, TK van den Berg, JG Damoiseaux: Monoclonal antibodies against rat macrophages. J Immunol Methods 174, 21-3 (1994) (Pubitemid 24297133)
17. Fabriek BO, ES Van Haastert, I Galea, MM Polfliet, ED Dopp, MM Van Den Heuvel, TK Van Den Berg, CJ De Groot, P Van Der Valk, CD Dijkstra: CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 51, 297-305 (2005) (Pubitemid 41532105)
18. Davalos D, J Grutzendler, G Yang, JV Kim, Y Zuo, S Jung, DR Littman, ML Dustin, WB Gan: ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8, 752-8 (2005) (Pubitemid 43085841)
19. Nimmerjahn A, F Kirchhoff, F Helmchen: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-8 (2005) (Pubitemid 40746128)
20. Garden GA, T Moller: Microglia biology in health anddisease. J Neuroimmune Pharmacol 1, 127-37 (2006)
21. Dheen ST, C Kaur, EA Ling: Microglial activation and its implications in the brain diseases. Curr Med Chem 14, 1189-97 (2007) (Pubitemid 46739320)
22. Hanisch UK, H Kettenmann: Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10, 1387-94 (2007) (Pubitemid 350014685)
23. Graeber MB, WJ Streit: Microglia: biology and pathology. Acta Neuropathol 119, 89-105 (2010)
24. Raivich G, R Banati: Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev 46, 261-81 (2004) (Pubitemid 39574328)
25. Chew LJ, A Takanohashi, M Bell: Microglia and inflammation: impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev 12, 105-12 (2006)
26. Ransohoff RM,VH Perry: Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27, 119-45 (2009)
27. Carson MJ, TV Bilousova, SS Puntambekar, B Melchior, JM. Doose, IM Ethell: A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 4, 571-9 (2007) (Pubitemid 47499284)
28. Lanzavecchia A: Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med, 185, 1717-9 (1997)
29. Kishimoto H,J Sprent: Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells. J Immunol 163, 1817-26 (1999) (Pubitemid 29382180)
30. Nurieva RI, X Liu, C Dong: Yin-Yang of costimulation: crucial controls of immune tolerance and function. Immunol Rev 229, 88-100 (2009)
31. Lenschow DJ, TL Walunas, JA Bluestone: CD28/B7 system of T cell costimulation. Annu Rev Immunol 14, 233-58 (1996) (Pubitemid 26130184)
32. Sansom DM: CD28, CTLA-4 and their ligands: who does what and to whom? Immunology 101, 169-77 (2000)
33. Salomon B, JA Bluestone: Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19, 225-52 (2001) (Pubitemid 32368035)
34. Sharpe AH, GJ Freeman: The B7-CD28 superfamily. Nat Rev Immunol 2, 116-26 (2002) (Pubitemid 37323235)
35. Karandikar NJ, CL Vanderlugt, TL Walunas, SD Miller, JA Bluestone: CTLA-4: a negative regulator of autoimmune disease. J Exp Med 184, 783-8 (1996) (Pubitemid 26324135)
36. de Jong EC, HH Smits, ML Kapsenberg: Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol 26, 289-307 (2005)
37. Mangan PR, LE Harrington, D B O'Quinn, WS Helms, DC Bullard, CO Elson, RD Hatton, SM Wahl, TR Schoeb, CT Weaver: Transforming growth factorbeta induces development of the T (H)17 lineage. Nature 441, 231-4 (2006)
38. Bettelli E, Y Carrier, W Gao, T Korn, TB Strom, M Oukka, HL Weiner, VK Kuchroo: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-8 (2006)
39. Kapsenberg ML: Dendritic-cell control of pathogendriven T-cell polarization. Nat Rev Immunol 3, 984-93 (2003) (Pubitemid 37521540)
40. Miranda de Carvalho C, C Bonnefont-Rebeix, D Rigal, L Chabanne: "Dendritic cells in different animal species: an overview". Pathol Biol (Paris) 54, 85-93 (2006)
41. Sato K & S Fujita: Dendritic cells: nature and classification. Allergol Int 56, 183-91 (2007)
42. Heath WR, FR Carbone: Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 10, 1237-44 (2009)
43. Banchereau J,RM Steinman: Dendritic cells and the control of immunity. Nature 392, 245-52 (1998) (Pubitemid 28155090)
44. Banchereau J, F Briere, C Caux, J Davoust, S Lebecque, YJ Liu, B Pulendran, K Palucka: Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811 (2000) (Pubitemid 30365397)
45. Steinman RM, D Hawiger, K Liu, L Bonifaz, D Bonnyay, K Mahnke, T Iyoda, J Ravetch, M Dhodapkar, K Inaba, M Nussenzweig: Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci 987, 15-25 (2003) (Pubitemid 36584003)
46. Hume DA: Macrophages as APC and the dendritic cell myth. J Immunol 181, 5829-35 (2008)
47. Medawar PB: Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29, 58-69 (1948)
48. Barker CF,RE Billingham: Immunologically privileged sites. Adv Immunol 25, 1-54 (1977)
49. Stevenson PG, S Hawke, DJ Sloan, CR Bangham: The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol 71, 145-51 (1997) (Pubitemid 26412275)
50. Matyszak MK, VH Perry: Bacillus Calmette-Guerin sequestered in the brain parenchyma escapes immune recognition. J Neuroimmunol 82, 73-80 (1998) (Pubitemid 28129338)
51. Aloisi F, B Serafini, L Adorini: Glia-T cell dialogue. J Neuroimmunol 107, 111-7 (2000) (Pubitemid 30347415)
52. Deng X, S Sriram: Role of microglia in multiple sclerosis. Curr Neurol Neurosci Rep 5, 239-44 (2005) (Pubitemid 40873040)
53. Reichmann G, M Schroeter, S Jander, HG Fischer: Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. J Neuroimmunol 129, 125-32 (2002) (Pubitemid 34874917)
54. Kostulas N, HL Li, BG Xiao, YM Huang, V Kostulas, H Link: Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 33, 1129-34 (2002) (Pubitemid 34293602)
55. Newman TA, I Galea, N van Rooijen, VH Perry: Blood-derived dendritic cells in an acute brain injury. J Neuroimmunol 166, 167-72 (2005) (Pubitemid 41074666)
56. Matyszak MK, VH Perry: The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74, 599-608 (1996) (Pubitemid 26274227)
57. Teixeira SA, AA Varriano, SM Bolonheis, MN Muscará: Experimental autoimmune encephalomyelitis: A heterogeneous group of animal models to study human multiple sclerosis. Drug Discovery Today: Disease Models 2, 127-134 (2005) (Pubitemid 40960353)
58. Wekerle H, FC Kurschus: Animal models of multiple sclerosis. Drug Discovery Today: Disease Models 3, 359-367 (2006) (Pubitemid 46179164)
59. Chin CL, M Pai, PF Bousquet, AJ Schwartz, EM O'Connor, CM Nelson, VP Hradil, BF Cox, BL McRae, GB Fox: Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways. J Neuroimmunol 211, 49-55 (2009)
60. MacKenzie-Graham A, MR Tinsley, KP Shah, C Aguilar, LV Strickland, J Boline, M Martin, L Morales, DW Shattuck, RE Jacobs, RR Voskuhl, AW. Toga: Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis. Neuroimage 32, 1016-23 (2006) (Pubitemid 44278686)
61. Engelhardt B, RM Ransohoff: The ins and outs of Tlymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26, 485-95 (2005) (Pubitemid 41139258)
62. Kuchroo VK, AC Anderson, H Waldner, M Munder, E Bettelli, LB Nicholson: T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu Rev Immunol 20, 101-23 (2002) (Pubitemid 34293422)
63. Reinhardt RL, SJ Kang, HE Liang, RM Locksley: T helper cell effector fates - who, how and where? Curr Opin Immunol 18, 271-7 (2006)
64. Dittel BN: CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS. Brain Behav Immun 22, 421-30 (2008)
65. Takatori H, Y Kanno, Z Chen, JJ O'Shea: New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol 18, 533-41 (2008)
66. Harrington LE, PR Mangan, CT Weaver: Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18, 349-56 (2006)
67. Aranami T, T Yamamura: Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int 57, 115-20 (2008) (Pubitemid 351897665)
68. Jager A, V Dardalhon, RA Sobel, E Bettelli, VK Kuchroo: Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183, 7169-77 (2009)
69. Murphy AC, SJ Lalor, MA Lynch, KH Mills: Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24, 641-51 (2010)
70. Kohm AP, PA Carpentier, HA Anger, SD Miller: Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169, 4712-6 (2002) (Pubitemid 35217131)
71. McGeachy MJ, LA Stephens, SM Anderton: Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 175, 3025-32 (2005) (Pubitemid 41170521)
72. Korn T, AC Anderson, E Bettelli, M Oukka: The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J Neuroimmunol 191, 51-60 (2007) (Pubitemid 350060999)
73. Zhang X, DN Koldzic, L Izikson, J Reddy, RF Nazareno, S Sakaguchi, VK Kuchroo, HL Weiner: IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16, 249-56 (2004) (Pubitemid 38195655)
74. Kohm AP, JS McMahon, JR Podojil, WS Begolka, M DeGutes, DJ Kasprowicz, SF Ziegler, SD Miller: Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 176, 3301-5 (2006) (Pubitemid 43363974)
75. Sun D, JN Whitaker, Z Huang, D Liu, C Coleclough, H Wekerle, CS Raine: Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 166, 7579-87 (2001) (Pubitemid 32525639)
76. Huseby ES, D Liggitt, T Brabb, B Schnabel, C Ohlen, J Goverman: A pathogenic role for myelin-specific CD8 (+) T cells in a model for multiple sclerosis. J Exp Med 194, 669-76 (2001) (Pubitemid 32844776)
77. Ford ML, BD Evavold: Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol 35, 76-85 (2005) (Pubitemid 40123854)
78. Wohler JE, SS Smith, SR Barnum: gammadelta T cells: the overlooked T-cell subset in demyelinating disease. J Neurosci Res 88, 1-6 (2010)
79. Matsumoto Y, K Ohmori, M Fujiwara: Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J Neuroimmunol 37, 23-33 (1992)
80. Gehrmann J, R Gold, C Linington, J Lannes-Vieira, H Wekerle, GW Kreutzberg: Microglial involvement in experimental autoimmune inflammation of the central and peripheral nervous system. Glia 7, 50-9 (1993)
81. Ponomarev ED, LP Shriver, K Maresz, BN Dittel: Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81, 374-89 (2005) (Pubitemid 41359292)
82. Craner MJ, TG Damarjian, S Liu, BC Hains, AC Lo, JA Black, J Newcombe, ML Cuzner, SG Waxman: Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 49, 220-9 (2005) (Pubitemid 40188501)
83. Brown DA, PE Sawchenko: Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol 502, 236-60 (2007) (Pubitemid 46595397)
84. Rasmussen S, Y Wang, P Kivisakk, RT Bronson, M Meyer, J Imitola, SJ Khoury: Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing - remitting experimental autoimmune encephalomyelitis. Brain 130, 2816-29 (2007) (Pubitemid 350033966)
85. Almolda B, M Costa, M Montoya, B Gonzalez, B Castellano: CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model. J Neuroimmunol 209, 65-80 (2009)
86. Bhasin M, M Wu, SE Tsirka: Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol 8, 10 (2007)
87. Guo X, K Nakamura, K Kohyama, C Harada, HA Behanna, DM Watterson, Y Matsumoto, T Harada: Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis. Neurosci Res 59, 457-66 (2007) (Pubitemid 350007814)
88. Heppner FL, M Greter, D Marino, J Falsig, G Raivich, N Hovelmeyer, A Waisman, T Rulicke, M Prinz, J Priller, B Becher, A Aguzzi: Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11, 146-52 (2005) (Pubitemid 40321349)
89. Mensah-Brown EP, A Shahin, LJ Garey, ML Lukic: Neuroglial response after induction of experimental allergic encephalomyelitis in susceptible and resistant rat strains. Cell Immunol 233, 140-7 (2005) (Pubitemid 41074067)
90. Gay F: Activated microglia in primary MS lesions: defenders or aggressors? Int MS J 14, 78-83 (2007) (Pubitemid 351311536)
91. Floris S, EL Blezer, G Schreibelt, E Dopp, SM van der Pol, IL Schadee-Eestermans, K Nicolay, CD Dijkstra, HE de Vries: Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127, 616-27 (2004) (Pubitemid 38295477)
92. Zhu B, Y Bando, S Xiao, K Yang, AC Anderson, VK Kuchroo, SJ Khoury: CD11b+Ly-6C (hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol 179, 5228-37 (2007)
93. Ifergan I, H Kebir, M Bernard, K Wosik, A Dodelet- Devillers, R Cayrol, N Arbour, A Prat: The blood-brain barrier induces differentiation of migrating monocytes into Th17- polarizing dendritic cells. Brain 131, 785-99 (2008) (Pubitemid 351294709)
94. Polfliet MM, F van de Veerdonk, EA Dopp, EM van Kesteren-Hendrikx, N van Rooijen, CD Dijkstra, TK van den Berg: The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J Neuroimmunol 122, 1-8 (2002)
95. Kawakami N, S Lassmann, Z Li, F Odoardi, T Ritter, T Ziemssen, WE Klinkert, JW Ellwart, M Bradl, K Krivacic, H Lassmann, RM Ransohoff, HD Volk, H Wekerle, C Linington, A Flugel: The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med, 199, 185-97 (2004) (Pubitemid 38129699)
96. Archambault AS, J Sim, MA Gimenez, JH Russell: Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur J Immunol 35, 1076-85 (2005) (Pubitemid 40542214)
97. Polfliet MM, PH Goede, EM van Kesteren-Hendrikx, N van Rooijen, CD Dijkstra, TK van den Berg: A method for the selective depletion of perivascular and meningeal macrophages in the central nervous system. J Neuroimmunol 116, 188-95 (2001)
98. Perry VH: A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J Neuroimmunol 90, 113-21 (1998)
99. Lindsey JW, L Steinman: Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class II mRNA in the central nervous system during development and resolution of experimental allergic encephalomyelitis. J Neuroimmunol 48, 227-34 (1993) (Pubitemid 24010179)
100. Pope JG, CL Vanderlugt, SM Rahbe, HL Lipton, SD Miller: Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus. J Virol 72, 7762-71 (1998) (Pubitemid 28421766)
101. Juedes AE, NH Ruddle: Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol 166, 5168-75 (2001) (Pubitemid 32280732)
102. Craggs RI, HD Webster: Ia antigens in the normal rat nervous system and in lesions of experimental allergic encephalomyelitis. Acta Neuropathol 68, 263-72 (1985) (Pubitemid 16194332)
103. Matsumoto Y, N Hara, R Tanaka, M Fujiwara: Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology. J Immunol 136, 3668-76 (1986) (Pubitemid 16122062)
104. Matsumoto Y, M Fujiwara: In situ detection of class I and II major histocompatibility complex antigens in the rat central nervous system during experimental allergic encephalomyelitis. An immunohistochemical study. J Neuroimmunol 12, 265-77 (1986) (Pubitemid 16013739)
105. McCombe PA, BW Fordyce, J de Jersey, G Yoong, MP Pender: Expression of CD45RC and Ia antigen in the spinal cord in acute experimental allergic encephalomyelitis: an immunocytochemical and flow cytometric study. J Neurol Sci 113, 177-86 (1992) (Pubitemid 23000565)
106. McCombe PA, J de Jersey, MP Pender: Inflammatory cells, microglia and MHC class II antigen-positive cells in the spinal cord of Lewis rats with acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 51, 153-67 (1994) (Pubitemid 24147482)
107. Stampachiacchiere B, L Aloe: Differential modulatory effect of NGF on MHC class I and class II expression in spinal cord cells of EAE rats. J Neuroimmunol 169, 20-30 (2005) (Pubitemid 41527088)
108. Nikodemova M, JJ Watters, SJ Jackson, SK Yang, ID Duncan: Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. J Biol Chem 282, 15208-16 (2007) (Pubitemid 47093379)
109. Linker RA, E Rott, HH Hofstetter, T Hanke, KV Toyka, R Gold: EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Neurobiol Dis 19, 218-28 (2005) (Pubitemid 40544739)
110. Linker RA, M Sendtner, R Gold: Mechanisms of axonal degeneration in EAE - lessons from CNTF and MHC I knockout mice. J Neurol Sci 233, 167-72 (2005) (Pubitemid 40804832)
111. Njenga MK, PD Murray, D McGavern, X Lin, KM Drescher, M Rodriguez: Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus. J Neuropathol Exp Neurol 58, 78-91 (1999) (Pubitemid 29053028)
112. Karandikar NJ, CL Vanderlugt, JA Bluestone, SD Miller: Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. J Neuroimmunol 89, 10-8 (1998) (Pubitemid 28389570)
113. Perrin PJ, CH June, JH Maldonado, RB Ratts, MK Racke: Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. J Immunol 163, 1704-10 (1999) (Pubitemid 29352797)
114. Girvin AM, MC Dal Canto, L Rhee, B Salomon, A Sharpe, JA Bluestone, SD Miller: A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J Immunol 164, 136-43 (2000) (Pubitemid 30012983)
115. Miller SD, CL Vanderlugt, DJ Lenschow, JG Pope, NJ Karandikar, MC Dal Canto, JA Bluestone: Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3, 739-45 (1995) (Pubitemid 26091147)
116. Chang TT, C Jabs, RA Sobel, VK Kuchroo, AH Sharpe: Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J Exp Med 190, 733-40 (1999) (Pubitemid 29428655)
117. Hurwitz AA, TJ Sullivan, MF Krummel, RA Sobel, JP Allison: Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J Neuroimmunol 73, 57-62 (1997) (Pubitemid 27105269)
118. Issazadeh S, V Navikas, M Schaub, M Sayegh, S Khoury: Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J Immunol 161, 1104-12 (1998) (Pubitemid 28380534)
119. Karandikar NJ, CL Vanderlugt, T Eagar, L Tan, JA Bluestone, SD Miller: Tissue-specific up-regulation of B7- 1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J Immunol 161, 192-9 (1998) (Pubitemid 28285523)
120. Mack CL, CL Vanderlugt-Castaneda, KL Neville, SD Miller: Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. J Neuroimmunol 144, 68-79 (2003) (Pubitemid 37329931)
121. Pender MP, KB Nguyen, PA McCombe, JF Kerr: Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104, 81-7 (1991)
122. Pender MP, PA McCombe, G Yoong, KB Nguyen: Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J Autoimmun 5, 401-10 (1992)
123. Schmied M, H Breitschopf, R Gold, H Zischler, G Rothe, H Wekerle, H Lassmann: Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 143, 446-52 (1993) (Pubitemid 24058199)
124. McCombe PA, I Nickson, Z Tabi, MP Pender: Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neurol Sci 139, 1-6 (1996) (Pubitemid 26246272)
125. Bohatschek M, CU Kloss, K Pfeffer, H Bluethmann, G Raivich: B7.2 on activated and phagocytic microglia in the facial axotomy model: regulation by interleukin-1 receptor type 1, tumor necrosis factor receptors 1 and 2 and endotoxin. J Neuroimmunol 156, 132-45 (2004) (Pubitemid 39304193)
126. Bechmann I, S Peter, M Beyer, U Gimsa, R Nitsch: Presence of B7-2 (CD86) and lack of B7-1 (CD (80) on myelin phagocytosing MHC-II-positive rat microglia is associated with nondestructive immunity in vivo. Faseb J 15, 1086-8 (2001)
127. Kwidzinski E, LK Mutlu, AD Kovac, J Bunse, J Goldmann, J Mahlo, O Aktas, F Zipp, T Kamradt, R Nitsch, I Bechmann: Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. J Neural Transm Supp l29-49 (2003)
128. Remington LT, AA Babcock, SP Zehntner, T Owens: Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol 170, 1713-24 (2007) (Pubitemid 47339315)
129. Lee KM, E Chuang, M Griffin, R Khattri, DK Hong, W Zhang, D Straus, LE Samelson, CB Thompson, JA Bluestone: Molecular basis of T cell inactivation by CTLA- 4. Science 282, 2263-6 (1998) (Pubitemid 29004076)
130. Takahashi T, T Tagami, S Yamazaki, T Uede, J Shimizu, N Sakaguchi, TW Mak, S Sakaguchi: Immunologic self-tolerance maintained by CD25 (+)CD4 (+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192, 303-10 (2000)
131. Bluestone JA, Q Tang: How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 17, 638-42 (2005) (Pubitemid 41506909)
132. Horwitz DA, SG Zheng, JD Gray: Natural and TGFbeta- induced Foxp3 (+)CD4 (+) CD25 (+) regulatory T cells are not mirror images of each other. Trends Immunol 29, 429-35 (2008)
133. Curotto de Lafaille MA, JJ Lafaille: Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30, 626-35 (2009)
134. Hori S, S Sakaguchi: Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 6, 745-51 (2004) (Pubitemid 38781186)
135. Zheng SG, JH Wang, W Stohl, KS Kim, JD Gray, DA Horwitz: TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 176, 3321-9 (2006) (Pubitemid 43363978)
136. Read S, R Greenwald, A Izcue, N Robinson, D Mandelbrot, L Francisco, AH Sharpe, F Powrie: Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 177, 4376-83 (2006) (Pubitemid 44469766)
137. Jain N, H Nguyen, C Chambers, J Kang: Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc Natl Acad Sci U S A 107, 1524-8 (2010)
138. Chitnis T, SJ Khoury: Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. J Allergy Clin Immunol 112, 837-49; quiz 850 (2003)
139. Gerritse K, JD Laman, RJ Noelle, AAruffo, JA Ledbetter, WJ Boersma, E Claassen: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 93, 2499-504 (1996) (Pubitemid 26104798)
140. Becher B, BG Durell, AV Miga, WF Hickey, RJ Noelle: The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med 193, 967-74 (2001) (Pubitemid 32525869)
141. Liang SC, YE Latchman, JE Buhlmann, MF Tomczak, BH Horwitz, GJ Freeman, AH Sharpe: Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 33, 2706-16 (2003) (Pubitemid 37337136)
142. Magnus T, B Schreiner, T Korn, C Jack, H Guo, J Antel, I Ifergan, L Chen, F Bischof, A Bar-Or, H Wiendl: Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci 25, 2537-46 (2005) (Pubitemid 40365165)
143. Carter LL, MW Leach, ML Azoitei, J Cui, JW Pelker, J Jussif, S Benoit, G Ireland, D Luxenberg, GR Askew, KL Milarski, C Groves, T Brown, BA Carito, K Percival, BM Carreno, M Collins, S Marusic: PD-1/PD-L1, but not PD- 1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 182, 124-34 (2007) (Pubitemid 46039761)
144. Wang C, Y Li, TM Proctor, AA Vandenbark, H Offner: Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis. J Neurosci Res 88, 7-15 (2010)
145. Dong C, AE Juedes, UA Temann, S Shresta, JP Allison, NH Ruddle, RA Flavell: ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409, 97-101 (2001) (Pubitemid 32098632)
146. Rottman JB, T Smith, JR Tonra, K Ganley, T Bloom, R Silva, B Pierce, JC Gutierrez-Ramos, E Ozkaynak, AJ Coyle: The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat Immunol 2, 605-11 (2001) (Pubitemid 32677627)
147. Liu YJ: Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259-62 (2001)
148. Liu K, GD Victora, TA Schwickert, P Guermonprez, MM Meredith, K Yao, FF Chu, GJ Randolph, AY Rudensky, M Nussenzweig: In vivo analysis of dendritic cell development and homeostasis. Science 324, 392-7 (2009)
149. McMenamin PG: Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the
150. McMenamin PG, RJ Wealthall, M Deverall, SJ Cooper, B Griffin: Macrophages and dendritic cells in the rat meninges and choroid plexus: three-dimensional localisation by environmental scanning electron microscopy and confocal microscopy. Cell Tissue Res 313, 259-69 (2003) (Pubitemid 37260433)
151. McMahon EJ, SL Bailey, SD Miller: CNS dendritic cells: critical participants in CNS inflammation? Neurochem Int 49, 195-203 (2006) (Pubitemid 43867078)
152. Israelsson C, H Bengtsson, A Lobell, LN Nilsson, A Kylberg, M Isaksson, H Wootz, L Lannfelt, K Kullander, L Hillered, T Ebendal: Appearance of Cxcl10-expressing cell clusters is common for traumatic brain injury and neurodegenerative disorders. Eur J Neurosci 31, 852-63 (2010)
153. Serafini B, S Columba-Cabezas, F Di Rosa, F Aloisi: Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 157, 1991-2002 (2000)
154. Fischer HG, G Reichmann: Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 166, 2717-26 (2001) (Pubitemid 32173513)
155. Bailey SL, B Schreiner, EJ McMahon, SD Miller: CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T (H)-17 cells in relapsing EAE. Nat Immunol 8, 172-80 (2007) (Pubitemid 46152648)
156. Zozulya AL, S Ortler, J Lee, C Weidenfeller, M Sandor, H Wiendl, Z Fabry: Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS. J Neurosci 29, 140-52 (2009)
157. Greter M, FL Heppner, MP Lemos, BM Odermatt, N Goebels, T Laufer, RJ Noelle, B Becher: Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11, 328-34 (2005) (Pubitemid 40460562)
158. Menges M, S Rossner, C Voigtlander, H Schindler, NA Kukutsch, C Bogdan, K Erb, G Schuler, MB Lutz: Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 195, 15-21 (2002) (Pubitemid 34074492)
159. Zozulya AL, BD Clarkson, S Ortler, Z Fabry, H Wiendl: The role of dendritic cells in CNS autoimmunity. J Mol Med 88, 535-44 (2010)
160. Adler HS, K Steinbrink: Tolerogenic dendritic cells in health and disease: friend and foe! Eur J Dermatol 17, 476-91 (2007) (Pubitemid 350207158)
161. Mueller DL: Mechanisms maintaining peripheral tolerance. Nat Immunol 11, 21-7 (2010)
162. Hackstein H, AW Thomson: Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4, 24-34 (2004) (Pubitemid 38084129)
163. Morelli AE, AW Thomson: Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7, 610-21 (2007) (Pubitemid 47123548)
164. Sakurai K, JP Zou, JR Tschetter, JM Ward, GM Shearer: Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 129, 186-96 (2002) (Pubitemid 34874924)
165. Kiefer R, T Schweitzer, S Jung, KV Toyka, HP Hartung: Sequential expression of transforming growth factor-beta1 by T-cells, macrophages, and microglia in rat spinal cord during autoimmune inflammation. J Neuropathol Exp Neurol 57, 385-95 (1998) (Pubitemid 28237322)
166. Ledeboer A, A Wierinckx, JG Bol, S Floris, C Renardel de Lavalette, HE De Vries, TK van den Berg, CD Dijkstra, FJ Tilders, AM van dam: Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE. J Neuroimmunol 136, 94-103 (2003) (Pubitemid 36298848)
167. Bulloch K, MM Miller, J Gal-Toth, TA Milner, A Gottfried-Blackmore, EM Waters, UW Kaunzner, K Liu, R Lindquist, MC Nussenzweig, RM Steinman & BS McEwen: CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J Comp Neurol 508, 687-710 (2008) (Pubitemid 351693557)
168. Serafini B, B Rosicarelli, R Magliozzi, E Stigliano, E Capello, GL Mancardi, F Aloisi: Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol 65, 124-41 (2006)
169. Busshoff U, A Hein, A Iglesias, R Dorries, A Regnier- Vigouroux: CD1 expression is differentially regulated by microglia, macrophages and T cells in the central nervous system upon inflammation and demyelination. J Neuroimmunol 113, 220-30 (2001) (Pubitemid 32112748)
170. Carson MJ, CR Reilly, JG Sutcliffe, D Lo: Mature microglia resemble immature antigen-presenting cells. Glia 22, 72-85 (1998) (Pubitemid 28038045)
171. Dominguez PM, C Ardavin: Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev 234, 90-104 (2010)
172. Geissmann F, MG Manz, S Jung, MH Sieweke, M Merad, K Ley: Development of monocytes, macrophages, and dendritic cells. Science 327, 656-61 (2010)
173. King IL, TL Dickendesher, BM Segal: Circulating Ly- 6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113, 3190-7 (2009)
174. Mosialos G, M Birkenbach, S Ayehunie, F Matsumura, GS Pinkus, E Kieff, E Langhoff: Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol 148, 593-600 (1996) (Pubitemid 26056743)
175. Ross R, H Jonuleit, M Bros, XL Ross, S Yamashiro, F Matsumura, AH Enk, J Knop, AB Reske-Kunz: Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation. J Invest Dermatol 115, 658-63 (2000)
176. Al-Alwan MM, G Rowden, T D. Lee, KA West: Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol 166, 338-45 (2001) (Pubitemid 32038450)